Evidence map›Paper›PMID 31750952›Full record

ArticleAllergy2020

TGFβ1 mimetic peptide modulates immune response to grass pollen allergens in mice.

Galber R Araujo, Lorenz Aglas, Emília R Vaz, Yoan Machado, Sara Huber, Martin Himly, Albert Duschl, Luiz R Goulart, Fatima Ferreira

Open access · hybridAbstract read
In one paragraph

Article in Allergy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Review
  3. The therapeutic potential ofFrontiers in pharmacology · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. How Do Pollen Allergens Sensitize?Frontiers in molecular biosciences · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Galber R AraujoDepartment of Biosciences, University of Salzburg, Salzburg, Austria.ORCID 0000-0001-6038-8893
Lorenz AglasDepartment of Biosciences, University of Salzburg, Salzburg, Austria.
Emília R VazLaboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, Brazil.
Yoan MachadoDepartment of Biosciences, University of Salzburg, Salzburg, Austria.
Sara HuberDepartment of Biosciences, University of Salzburg, Salzburg, Austria.
Martin HimlyDepartment of Biosciences, University of Salzburg, Salzburg, Austria.
Albert DuschlDepartment of Biosciences, University of Salzburg, Salzburg, Austria.
Luiz R GoulartLaboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, Brazil.
Fatima FerreiraDepartment of Biosciences, University of Salzburg, Salzburg, Austria.ORCID 0000-0003-0989-2335
University of Salzburg · ATUniversidade Federal de Uberlândia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTransforming growth factor β1 (TGFβ1) is a cytokine that exerts immunosuppressive functions, as reflected by its ability to induce regulatory T (Treg) cell differentiation and inhibit Th1 and Th2 responses. Hence, peptides that mimic the active core domain of TGFβ1 may be promising candidates for modulation of the allergic response. This study aimed to investigate a synthetic TGFβ1 mimetic peptide (TGFβ1-mim) for its ability to modulate the immune response during allergic sensitization to grass pollen allergens.

methodsThe in vitro action of TGFβ1-mim was evaluated in human lung epithelial cells, Jurkat cells, and rat basophilic leukemia cells. The in vivo action was evaluated in a murine model of Phl p 5 allergic sensitization. Additionally, the Th2 modulatory response was evaluated in IL-4 reporter mice.

resultsIn vitro, TGFβ1-mim downregulated TNF-α production, IL-8 gene expression, and cytokine secretion, upregulated IL-10 secretion, and inhibited Phl p 5-induced basophil degranulation. During Phl p 5 sensitization in mice, TGFβ1-mim downregulated IL-2, IL-4, IL-5, IL-13, and IFN-γ, upregulated IL-10, and induced Treg cell production. Furthermore, mice treated with TGFβ1-mim had lower levels of IgE, IgG1, IgG2a and higher levels of IgA antibodies than control mice. In a reporter mouse, the mimetic inhibited Th2 polarization.

conclusionThe TGFβ1-mim efficiently modulated various important events that exacerbate the allergic microenvironment, including the production of main cytokines that promote Th1 and Th2 differentiation, and the induction of allergen-specific regulatory T cells, highlighting its potential use in therapeutic approaches to modulate the immune response toward environmental allergens.

Indexed as

AllergensPeptidesTransforming Growth Factor beta1AnimalsBiomimeticsImmunoglobulin EMicePoaceaePollenAllergensImmunoglobulin EPeptidesTransforming Growth Factor beta1allergic sensitizationgrass pollen allergyimmune regulationimmunotherapyTGFβ1

Identifiers

PMID31750952
PMCPMC7217028
OpenAlexW2990400671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.